• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Healthcare·STXS
Share

Stereotaxis, Inc. Stocks

$ 1.84Last Updated 12.06.2026

Issuer Rating

2/7
Performance

Modest

Risk

High

Recommendation

Sell

Market Cap

$ 176.90M

$ 1.84
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Favourable analyst view

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Latest news

07.10.2025 12:20

Smart machines: Which small caps to bet on in the robotics boom

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Stereotaxis, Inc. specializes in the development, manufacturing, and commercialization of robotic systems, specialized instruments, and information management solutions for interventional laboratories, serving both domestic and international markets. A cornerstone of their product portfolio is their robotic magnetic navigation (RMN) technology, embodied by the Genesis RMN and Niobe systems. These innovative platforms empower clinicians to perform intricate interventional procedures by precisely guiding catheters and guidewires, under image guidance, through the vasculature and heart chambers to specific treatment sites. The company further delivers Odyssey, an advanced real-time information system designed to facilitate the management, control, recording, and secure sharing of procedural data across various networks. For robotic interventional operating rooms, Stereotaxis offers the Imaging Model S X-ray system, a comprehensive single-plane X-ray unit complete with a c-arm, powered table, motorized boom, and high-definition monitors. Complementing its primary systems, Stereotaxis provides a range of disposable components and accessories. This includes QuikCAS, which enables automated, remote advancement of electrophysiology catheters, as well as various steerable tip diagnostic and ablation catheters like the CARTO RMT, CELSIUS RMT, and several NAVISTAR RMT models, some featuring irrigated tips. Additionally, they offer Vdrive, a system engineered to enhance the navigation and stability of diagnostic and therapeutic devices during interventional procedures, alongside disposable elements such as V-Loop, V-Sono, and V-CAS. Stereotaxis distributes its offerings through a combination of its dedicated direct sales force, distributors, and sales agents. The company has also forged a strategic alliance with Osypka AG to jointly develop a magnetic ablation catheter leveraging Stereotaxis' proprietary robotic technology. Founded in 1990, Stereotaxis, Inc. maintains its headquarters in Saint Louis, Missouri.

Company Valuation

Greatly overvalued
1/7

Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers.

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Favourable
6/7

The average target price of STXS is 4.3 and suggests 134% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increa

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

13.06.2026 03:02

Microsoft is considering spinning off Xbox into a separate company - The Information

13.06.2026 01:40

Hope for peace with Iran and SpaceX lifted spirits: stocks rose for second straight day

13.06.2026 01:05

SpaceX shares rose in value by 19% on the first day of trading. Is it worth buying them?

13.06.2026 01:04

SpaceX shares slowed before closing in first trading since record IPO

13.06.2026 00:44

Retail investors bought $15 billion worth of SpaceX stock. Demand was at least 6 times that amount

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn
  • X (Twitter)
  • LinkedIn
Oninvest© 2026